HomeGUD • TSE
add
Knight Therapeutics Inc
Previous close
$6.29
Day range
$6.30 - $6.48
Year range
$5.09 - $6.48
Market cap
637.78M CAD
Avg Volume
52.31K
P/E ratio
58.92
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 88.08M | 1.70% |
Operating expense | 40.40M | 3.49% |
Net income | 2.18M | 148.06% |
Net profit margin | 2.48 | 147.24% |
Earnings per share | 0.02 | 150.00% |
EBITDA | 6.05M | -60.32% |
Effective tax rate | 647.62% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 159.99M | -16.70% |
Total assets | 1.00B | 3.60% |
Total liabilities | 207.60M | 0.62% |
Total equity | 795.44M | — |
Shares outstanding | 99.63M | — |
Price to book | 0.79 | — |
Return on assets | -1.41% | — |
Return on capital | -1.63% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 2.18M | 148.06% |
Cash from operations | 3.67M | -88.12% |
Cash from investing | 32.13M | 231.85% |
Cash from financing | -4.70M | -62.20% |
Net change in cash | 32.05M | 686.67% |
Free cash flow | -28.43M | -3,045.99% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
745
